Tag:
epilepsy
Latest Headlines
Latest Headlines
Implant successfully predicts human epilepsy seizures
NeuroVista's implantable device successfully and correctly predicted epilepsy seizures in some adults for whom drugs haven't worked, a new proof-of-concept study found.
NeuroPace wins FDA panel vote for epilepsy implant
NeuroPace is on the path to FDA approval for its anti-epilepsy neurostimulation device, winning unanimous backing from the agency's neurological devices panel.
Philips spinout grabs $9.9M for Parkinson's DBS trial
A spinout of the Dutch conglomerate Royal Philips Electronics nabbed nearly $10 million in new venture funding to back ongoing development of a deep-brain stimulation implant to treat Parkinson's disease.
UPDATED: Pfizer hits ups, downs with controlled-release Lyrica
Lyrica, Pfizer's once-daily controlled-release formulation of pregabalin, missed the main endpoint of the first of three Phase III studies, according to a press release from the company.
Pfizer whiffs in PhIII study with controlled-release Lyrica
The study, which tested the formulation as a once-a-day therapy, missed its main goal of changing seizure frequency compared with placebo.
Investors celebrate as Cyberonics' neurostim device sales soar
Cyberonics ($CYBX) bucked sluggish sales trends elsewhere in the medical device industry and reported strong financial results for its fiscal 2013 second quarter. Investors reacted well to the news, driving the stock up more than 7% in late morning trading to $50 per share.
Epilepsy drug boosts brain function in Alzheimer's preclinical tests
Keppra (levetiracetam) gained approval 13 years ago as a treatment for epilepsy. But just as many drugs end up having unexpected uses in other indications, Keppra could also help treat some patients suffering from Alzheimer's disease, researchers from the Gladstone Institutes in San Francisco believe.
Genetic mutation behind rare childhood paralysis
A genetic biomarker for the very rare and severe form of paralysis in children--alternating hemiplegia of childhood--could help speed up correct diagnosis, prevent misdiagnosis and inappropriate treatment, and may even lead to new therapeutics for this currently incurable disability. The mutated gene was found by a team including researchers from Duke University Medical Center.
Supernus shares soar on epilepsy drug OK
Shares of Supernus Pharmaceuticals rocketed up more than 100% yesterday as word spread that the FDA had provided a tentative approval for its extended-release version of the generic epilepsy drug Topamax.
Supernus plots product launches as it dusts off $76M IPO attempt
Supernus Pharmaceuticals has finally dusted off the paperwork and suggested a $12 to $14 price range on some 5.8 million shares.
